
    
      STUDY OBJECTIVES

      The primary objectives of the study include:

        1. examine the effect of brexpiprazole treatment on the number of days of substance use in
           the past week as measured by the Timeline Follow-Back (TLFB) assessment;

        2. examine the effect of brexpiprazole treatment on substance craving using 100-mm visual
           analogue scale (VAS).

      The secondary objectives are to examine the effect of brexpiprazole treatment on:

        1. the dollar amount spent on substances in the past week;

        2. the psychiatric symptoms as measured using PANSS
    
  